Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-Bipolar RCT: Low-dose aspirin as add-on therapy in bipolar disorder
2021-000862-14Phase 4Completed
- Sponsor
- Copenhagen Affective Disorder Research Center
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bipolar disorder (BD) comparing Low-dose aspirin add-on with Placebo add-on (2 arms). Primary endpoint: Mood stabilization. Started Mar 2021; status: completed.
02
Drugs
aspirin
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on 2021-000862-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000862-14.